NBRTX
Price
$28.78
Change
-$0.10 (-0.35%)
Updated
Nov 13 closing price
VMVAX
Price
$88.78
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

NBRTX vs VMVAX

Header iconNBRTX vs VMVAX Comparison
Open Charts NBRTX vs VMVAXBanner chart's image
Neuberger Berman M/C Intrinsic Val Inst
Price$28.78
Change-$0.10 (-0.35%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$88.78
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
NBRTX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NBRTX vs. VMVAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBRTX is a Buy and VMVAX is a Buy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.9B vs. NBRTX (59.1M). VMVAX pays higher dividends than NBRTX: VMVAX (2.14) vs NBRTX (0.66). NBRTX was incepted earlier than VMVAX: NBRTX (15 years) vs VMVAX (13 years). VMVAX is a more actively managed with annual turnover of: 22.00 vs. NBRTX (15.00). VMVAX has a lower initial minimum investment than NBRTX: VMVAX (3000) vs NBRTX (1000000). VMVAX annual gain was more profitable for investors over the last year : 28.30 vs. NBRTX (26.29). VMVAX (48.86) and NBRTX (47.13) have equivalent 5 years return.
NBRTXVMVAXNBRTX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years13 years-
Gain YTD13.29918.47672%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets59.1M30.9B0%
Annual Yield % from dividends0.662.1431%
Returns for 1 year26.2928.3093%
Returns for 3 years11.9514.9880%
Returns for 5 years47.1348.8696%
Returns for 10 years27.92100.7228%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OII27.83-0.47
-1.66%
Oceaneering International
DAY77.17-1.79
-2.27%
Dayforce
ALLO2.73-0.11
-3.87%
Allogene Therapeutics
UCAR6.43-0.32
-4.71%
U Power Limited
TOI0.26-0.03
-9.03%
Oncology Institute (The)